A new proteomic aging clock may predict biological age, mortality risk, and the likelihood of age-related diseases, though ...

Advanced proteomic organ ageing is associated with the long-term risk of age-related diseases. In most cases, faster ageing ...

Abdominal aortic aneurysm (AAA) is a severe aortic disease for which no pharmacological interventions have yet been developed. This investigation focused on identifying protein‐based therapeutic ...

Exosomes, the small extracellular vesicles secreted by nearly all cell types, have emerged as powerful players in intercellular communication and potential biomarkers for disease diagnosis and therapy ...

Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will showcase new findings at the 21st Annual US ...

Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (Nasdaq: BACK), today announced the completed transfer of Proprietary Laboratory Analyses (PLA) code 0249U – originally issued to Theralink ...

Studying the cellular proteomic changes in response to these therapies yields critical biological insights that can drive further improvements in our ability to treat cancer. Additional ...